CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR) , a biopharmaceutical research and medical device company focused on early detection and treatment of reproductive-tract cancers, today announced that it has entered into a five-year agreement with three one-year “evergreen” extensions with Grupo Palex SA for distribution of the SoftPap(TM) Cervical Cell Collector into Spain. Palex is one of Europe’s leading distributors of medical products and services to hospitals. Palex’s agreement calls for minimum sales of 600K units the first year, 1.2mm units the second, 2.4mm units minimum the third year, with 10% increases each year thereafter.
